Metropolitan Life Insurance Company (MetLife)’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,723
| Closed | -$1.26M | – | 2146 |
|
|
2024
Q1 | $1.26M | Sell |
9,723
-89
| -0.9% | -$10.8K | 0.05% | 291 |
|
|
2023
Q4 | $1.12M | Sell |
9,812
-151
| -2% | -$15.1K | 0.05% | 299 |
|
|
2023
Q3 | $907K | Sell |
9,963
-463
| -4% | -$47.8K | 0.05% | 316 |
|
|
2023
Q2 | $1.17M | Buy |
10,426
+2,365
| +29% | +$250K | 0.06% | 294 |
|
|
2023
Q1 | $844K | Sell |
8,061
-2,361
| -23% | -$247K | 0.04% | 355 |
|
|
2022
Q4 | $1.15M | Sell |
10,422
-147
| -1% | -$15.4K | 0.05% | 336 |
|
|
2022
Q3 | $923K | Sell |
10,569
-120
| -1% | -$10.9K | 0.04% | 372 |
|
|
2022
Q2 | $836K | Sell |
10,689
-284
| -3% | -$23.4K | 0.04% | 410 |
|
|
2022
Q1 | $936K | Sell |
10,973
-14,952
| -58% | -$1.43M | 0.03% | 431 |
|
|
2021
Q4 | $3.11M | Sell |
25,925
-623
| -2% | -$77.3K | 0.04% | 346 |
|
|
2021
Q3 | $3.28M | Sell |
26,548
-873
| -3% | -$112K | 0.05% | 318 |
|
|
2021
Q2 | $3.29M | Buy |
27,421
+5,383
| +24% | +$615K | 0.05% | 325 |
|
|
2021
Q1 | $2.32M | Sell |
22,038
-1,081
| -5% | -$110K | 0.03% | 459 |
|
|
2020
Q4 | $2.35M | Sell |
23,119
-1,097
| -5% | -$103K | 0.04% | 410 |
|
|
2020
Q3 | $2.04M | Sell |
24,216
-1,080
| -4% | -$84.1K | 0.03% | 409 |
|
|
2020
Q2 | $1.64M | Sell |
25,296
-9,834
| -28% | -$649K | 0.03% | 477 |
|
|
2020
Q1 | $2.29M | Sell |
35,130
-499
| -1% | -$39.3K | 0.05% | 335 |
|
|
2019
Q4 | $2.81M | Buy |
35,629
+25
| +0.1% | +$1.95K | 0.04% | 369 |
|
|
2019
Q3 | $2.83M | Buy |
35,604
+3,997
| +13% | +$314K | 0.05% | 338 |
|
|
2019
Q2 | $2.64M | Buy |
31,607
+1,990
| +7% | +$159K | 0.04% | 379 |
|
|
2019
Q1 | $2.34M | Sell |
29,617
-1,231
| -4% | -$89.8K | 0.04% | 406 |
|
|
2018
Q4 | $2.06M | Sell |
30,848
-275
| -0.9% | -$19K | 0.04% | 404 |
|
|
2018
Q3 | $2.49M | Sell |
31,123
-925
| -3% | -$69.1K | 0.04% | 405 |
|
|
2018
Q2 | $2.16M | Buy |
32,048
+109
| +0.3% | +$7.92K | 0.04% | 469 |
|
|
2018
Q1 | $2.46M | Buy |
31,939
+202
| +0.6% | +$14.9K | 0.03% | 415 |
|
|
2017
Q4 | $2.16M | Sell |
31,737
-57,199
| -64% | -$3.8M | 0.03% | 498 |
|
|
2017
Q3 | $5.57M | Sell |
88,936
-1,345
| -1% | -$80.4K | 0.03% | 523 |
|
|
2017
Q2 | $5M | Sell |
90,281
-1,821
| -2% | -$94.8K | 0.03% | 577 |
|
|
2017
Q1 | $4.63M | Sell |
92,102
-1,278
| -1% | -$62.3K | 0.03% | 641 |
|
|
2016
Q4 | $4.62M | Sell |
93,380
-2,954
| -3% | -$150K | 0.03% | 614 |
|
|
2016
Q3 | $5.05M | Sell |
96,334
-815
| -0.8% | -$40K | 0.04% | 527 |
|
|
2016
Q2 | $4.34M | Buy |
97,149
+3,450
| +4% | +$150K | 0.03% | 596 |
|
|
2016
Q1 | $3.83M | Sell |
93,699
-2,176
| -2% | -$80.1K | 0.03% | 642 |
|
|
2015
Q4 | $3.5M | Sell |
95,875
-3,472
| -3% | -$126K | 0.03% | 660 |
|
|
2015
Q3 | $3.26M | Sell |
99,347
-1,735
| -2% | -$58.4K | 0.02% | 702 |
|
|
2015
Q2 | $3.75M | Sell |
101,082
-6,753
| -6% | -$246K | 0.03% | 689 |
|
|
2015
Q1 | $3.78M | Sell |
107,835
-1,095
| -1% | -$38.6K | 0.03% | 646 |
|
|
2014
Q4 | $4.15M | Buy |
108,930
+646
| +0.6% | +$23.6K | 0.03% | 630 |
|
|
2014
Q3 | $3.84M | Sell |
108,284
-2,286
| -2% | -$84.9K | 0.03% | 644 |
|
|
2014
Q2 | $4.32M | Sell |
110,570
-894
| -0.8% | -$33.4K | 0.03% | 613 |
|
|
2014
Q1 | $4.06M | Sell |
111,464
-1,660
| -1% | -$60.5K | 0.03% | 639 |
|
|
2013
Q4 | $3.91M | Sell |
113,124
-3,181
| -3% | -$102K | 0.03% | 632 |
|
|
2013
Q3 | $3.25M | Sell |
116,305
-635
| -0.5% | -$16.9K | 0.02% | 679 |
|
|
2013
Q2 | $3.15M | Buy |
+116,940
| New | +$3.23M | 0.03% | 667 |
|
Other funds holding XYL
Metropolitan Life Insurance Company (MetLife)'s XYL Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Xylem (XYL) in Q2 2024, closing a stake of 9,723 shares — an estimated $1.26M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in XYL in Q2 2013 and held it in 44 quarters. The position peaked at $5.57M in Q3 2017. 1,035 funds tracked by Wall St. Rank hold XYL as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Xylem position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 9,723 Xylem shares in Q2 2024, an estimated $1.26M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Xylem in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Xylem position peaked at $5.57M in Q3 2017.
- 1,035 funds tracked by Wall St. Rank held Xylem as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.